000132932 001__ 132932
000132932 005__ 20240303003330.0
000132932 0247_ $$2doi$$a10.1159/000485741
000132932 0247_ $$2pmid$$apmid:29587290
000132932 0247_ $$2ISSN$$a0012-2823
000132932 0247_ $$2ISSN$$a0301-164X
000132932 0247_ $$2ISSN$$a0365-8228
000132932 0247_ $$2ISSN$$a0365-8325
000132932 0247_ $$2ISSN$$a1421-9867
000132932 0247_ $$2altmetric$$aaltmetric:153835480
000132932 037__ $$aDKFZ-2018-00571
000132932 041__ $$aeng
000132932 082__ $$a610
000132932 1001_ $$0P:(DE-HGF)0$$aBenzel, Julia$$b0$$eFirst author
000132932 245__ $$aChemoprevention and Treatment of Pancreatic Cancer: Update and Review of the Literature.
000132932 260__ $$aBasel$$bKarger$$c2018
000132932 3367_ $$2DRIVER$$aarticle
000132932 3367_ $$2DataCite$$aOutput Types/Journal article
000132932 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1527241637_13187$$xReview Article
000132932 3367_ $$2BibTeX$$aARTICLE
000132932 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000132932 3367_ $$00$$2EndNote$$aJournal Article
000132932 520__ $$aPancreatic ductal adenocarcinoma is one of the most lethal types of cancer with a 5-year survival rate of around 7%. Due to the relatively poor prognosis, the potential need of an effective chemoprevention is highly needed.Different risk factors like smoking or hereditary tumour syndromes should be known for early detection of pancreatic intraepithelial neoplasia. Chemopreventive dietary agents include curcumin, capsaicin and flavonoid, whereas potential chemopreventive drugs compromise aspirin, metformin or statins. This review aims to give an overview on potential risk factors for the development of pancreatic cancer. Furthermore, we try to summarise known chemopreventive agents to support the fight against this lethal disease. Key Messages: On the one hand, there are natural agents that exhibit preventive properties and can lead to the prohibition of pancreatic cancer. On the other hand, there are drugs and agents that are currently used in other contexts and are thus already approved and studied in terms of their mechanisms of effects and the related secondary effects.
000132932 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000132932 588__ $$aDataset connected to CrossRef, PubMed,
000132932 7001_ $$aFendrich, Volker$$b1
000132932 773__ $$0PERI:(DE-600)1482218-0$$a10.1159/000485741$$gVol. 97, no. 4, p. 275 - 287$$n4$$p275 - 287$$tDigestion$$v97$$x1421-9867$$y2018
000132932 909CO $$ooai:inrepo02.dkfz.de:132932$$pVDB
000132932 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000132932 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000132932 9141_ $$y2018
000132932 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000132932 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000132932 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bDIGESTION : 2015
000132932 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000132932 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000132932 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000132932 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000132932 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000132932 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000132932 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000132932 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000132932 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000132932 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000132932 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000132932 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000132932 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000132932 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x0
000132932 980__ $$ajournal
000132932 980__ $$aVDB
000132932 980__ $$aI:(DE-He78)B062-20160331
000132932 980__ $$aUNRESTRICTED